Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank.The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol.The Navigation Guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth.Assessing bias in osteoarthritis trials included in Cochrane reviews: protocol for a meta-epidemiological studyConflicts of interest in nutritional sciences: The forgotten bias in meta-analysis.Industry Support of Medical Research: Important Opportunity or Treacherous Pitfall?Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviewsHow credible are the study results? Evaluating and applying internal validity tools to literature-based assessments of environmental health hazards.Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study.Effect of standardized training on the reliability of the Cochrane risk of bias assessment tool: a study protocol.Effect of standardized training on the reliability of the Cochrane risk of bias assessment tool: a prospective study.Randomized clinical trials in dentistry: Risks of bias, risks of random errors, reporting quality, and methodologic quality over the years 1955-2013.What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder?Response to: The evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder is in fact flawed.Using risk of bias domains to identify opportunities for improvement in food- and nutrition-related research: An evaluation of research type and design, year of publication, and source of funding.
P2860
Q22061981-BA7BDD43-DC5C-4A01-868F-0124ED154567Q33456912-D5F3F08D-A361-4FE2-A425-EE970ADD4D3FQ33898415-9FCE3841-9E90-42FD-8B5B-6CFD368BC3E4Q34264322-C14421F4-4FB7-4407-A3FA-0C0624BF2D88Q34275367-71ADD55B-9E57-483F-8E41-A7E6085F9B79Q34299192-B9066217-B06F-4841-8771-13A6B8DBC580Q36391292-3CE3258C-24FB-4870-8304-C55B0D76A8C6Q36484339-37C0AB17-F9DA-4F9C-907D-68DAF8405E4DQ36887082-3A6534BD-2E0F-42F3-BDA2-88EEC40744E8Q36994018-AA8E6980-3652-4D63-8BCF-9A6F2AF3AFC7Q37080259-C97221E6-651B-4598-9B8E-E6A6821923C3Q38286202-F167529A-055E-467F-837D-68B5E0A1DE04Q38932863-4D41B1D4-9610-44C1-A072-11678C74DC94Q47259028-4E1751A8-96DA-4FA5-A4FA-A2F20AAD76E4Q47806652-17D90220-E7B5-487D-9ABF-88018E9ECF72Q48770818-BF57A1E4-7DA6-4CF0-B9F1-386EC92ADF63Q55714559-52CA3CF1-070A-45D7-9109-5969A7EBCED8
P2860
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
@ast
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
@en
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
@en-gb
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
@nl
type
label
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
@ast
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
@en
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
@en-gb
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
@nl
prefLabel
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
@ast
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
@en
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
@en-gb
Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item
@nl
P3181
P1476
Why the Cochrane risk of bias tool should not include funding source as a standard item
@en
P2093
Jonathan AC Sterne
P304
P3181
P356
10.1002/14651858.ED000076
P577
2013-12-20T00:00:00Z